RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,205,497 | -13.1% | 941,895 | -15.1% | 0.26% | -4.4% |
| Q2 2023 | $8,287,181 | +12.0% | 1,109,395 | 0.0% | 0.27% | +21.3% |
| Q1 2023 | $7,399,665 | -13.5% | 1,109,395 | 0.0% | 0.22% | -18.2% |
| Q4 2022 | $8,553,435 | -27.5% | 1,109,395 | 0.0% | 0.28% | -10.4% |
| Q3 2022 | $11,804,000 | +30.7% | 1,109,395 | 0.0% | 0.31% | +21.3% |
| Q2 2022 | $9,030,000 | +13.7% | 1,109,395 | 0.0% | 0.25% | +75.7% |
| Q1 2022 | $7,943,000 | -58.2% | 1,109,395 | 0.0% | 0.14% | -41.0% |
| Q4 2021 | $19,004,000 | -25.6% | 1,109,395 | 0.0% | 0.24% | +1.7% |
| Q3 2021 | $25,527,000 | -37.0% | 1,109,395 | 0.0% | 0.24% | -29.2% |
| Q2 2021 | $40,493,000 | – | 1,109,395 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 5,977,631 | $42,800,000 | 100.00% |
| Two Sigma Ventures, LP | 1,806,800 | $12,937,000 | 74.73% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $28,290,000 | 31.54% |
| MV Management XI, L.L.C. | 1,971,908 | $14,119,000 | 9.80% |
| Data Collective IV GP, LLC | 5,941,120 | $42,538,000 | 9.03% |
| ArchPoint Investors | 1,267,430 | $9,075,000 | 3.13% |
| MIC Capital Management UK LLP | 1,388,889 | $9,944,000 | 1.94% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $10,806,000 | 1.09% |
| Samsara BioCapital, LLC | 539,236 | $3,861,000 | 0.97% |
| Pinz Capital Management, LP | 142,168 | $1,018,000 | 0.64% |